OCTOBER, 2014 Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm | ||||
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,852,920 | Micro-chamber plate, manufacturing method thereof | Bioneer Corporation | 7-Oct-14 | Korea |
8,865,467 | Single lentiviral vector system for induced pluripotent (iPS) stem cells derivation | Boston Medical Center Corporation | 21-Oct-14 | United States |
8,865,467 | Single lentiviral vector system for induced pluripotent (iPS) stem cells derivation | Boston Medical Center Corporation | 28-Oct-14 | United States |
8,871,488 | Recombinant host cells comprising phosphoketolases | Butamax Advanced Biofuels LLC | 28-Oct-14 | United States |
8,865,408 | Signature for the diagnosis of cancer aggressiveness and genetic instability | Centre National de la Recherche Scientifique | 28-Oct-14 | France |
8,865,408 | Signature for the diagnosis of cancer aggressiveness and genetic instability | Centre National de la Recherche Scientifique (CNRS) | 21-Oct-14 | France |
8,859,197 | Sperm-specific cation channel, CATSPER3, and uses therefor | Children's Medical Center Corporation | 14-Oct-14 | United States |
8,852,860 | Sperm-specific cation channel, CatSper1 and uses therefor | Children's Medical Center Corporation | 7-Oct-14 | United States |
8,871,509 | Nanoparticle-based gene delivery systems | Chung-Ang University-Academy Corporation Foundation | 28-Oct-14 | Korea |
8,852,890 | Production of bacterial strains | Danisco US Inc. | 7-Oct-14 | United States |
8,852,866 | Method for producing and identifying soluble protein domains | Domainex Limited | 7-Oct-14 | United Kingdom |
8,859,203 | Method for typing and detecting HBV | Fujirebio Europe N.V. | 14-Oct-14 | Netherlands |
8,859,256 | Method for detecting replication or colonization of a biological therapeutic | Genelux Corporation | 14-Oct-14 | United States |
8,865,399 | Phage-mediated bioluminescent detection of Yersinia pestis | Guild Associates, Inc. | 28-Oct-14 | United States |
8,865,399 | Phage-mediated bioluminescent detection of Yersinia pestis | Guild Associates, Inc. | 21-Oct-14 | United States |
8,859,276 | Recombinant Novirhabdoviruses and uses thereof | Institut National de la Recherche Agronomique | 14-Oct-14 | France |
8,871,503 | Construct | Isis Innovation Limited | 28-Oct-14 | United Kingdom |
8,871,515 | Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof | Isogenis, Inc. | 28-Oct-14 | United States |
8,852,943 | Method of modifying target region in host DNA and selectable marker cassette | Kao Corporation | 7-Oct-14 | Japan |
8,871,444 | In vitro evolution in microfluidic systems | Medical Research Council | 28-Oct-14 | United Kingdom |
8,871,460 | Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor | Neurogenetic Pharmaceuticals, Inc. | 28-Oct-14 | United States |
8,871,439 | Serum-free stable transfection and production of recombinant human proteins in human cell lines | Octapharma AG | 28-Oct-14 | Switzerland |
8,852,941 | Method for producing induced pluripotent stem cells | Osaka University | 7-Oct-14 | Japan |
8,871,440 | Method for evaluation of tissue preservation solution | Otsuka Pharmaceutical Factory, Inc. | 28-Oct-14 | Japan |
8,871,478 | Coryneform bacterium transformant and process for producing isobutanol using the same | Research Institute of Innovative Technology for the Earth | 28-Oct-14 | Japan |
8,852,942 | Cineraria-derived chromosomal DNA involved in synthesis of flavonoid, and use thereof | Suntory Holdings Limited | 7-Oct-14 | Japan |
8,859,274 | Antibody fragment-targeted immunoliposomes for systemic gene delivery | SynerGene Therapeutics, Inc. | 14-Oct-14 | United States |
8,865,469 | Methods of transforming a Listeria | The Regents of the University of California | 21-Oct-14 | United States |
8,865,469 | Methods of transforming a Listeria | The Regents of the University of California | 28-Oct-14 | United States |
8,852,930 | In vivo gene regulation by the combination of knock-in-tetO sequence into the genome and tetracycline-controlled trans-suppressor (tTS) protein | The Trustees of Columbia University in the City of New York | 7-Oct-14 | United States |
8,852,906 | Thermophilic micro-organisms for ethanol production | TMO Renewables Limited | 7-Oct-14 | United Kingdom |
8,859,260 | Expression cassette for lactase dehydrogenase, transformed yeast and method of producing lactic acid | Toray Industries, Inc. | 14-Oct-14 | Japan |
8,871,494 | Over-production of secondary metabolites by over-expression of the VEA gene | Wisconsin Alumni Research Foundation | 28-Oct-14 | United States |
8,865,409 | Assay methods for MDV-1 | Zoetis W LLC | 21-Oct-14 | United States |
8,865,409 | Assay methods for MDV-1 | Zoetis W LLC | 28-Oct-14 | United States |
DATA PROCESSING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,868,349 | Methods, systems, and products for quantitatively measuring the degree of concordance between or among microarray probe level data sets | Dart Neuroscience (Cayman) Ltd. | 21-Oct-14 | United States |
8,868,349 | Methods, systems, and products for quantitatively measuring the degree of concordance between or among microarray probe level data sets | Dart Neuroscience (Cayman) Ltd. | 28-Oct-14 | Cayman |
8,868,352 | Predicting response to chemotherapy using gene expression markers | Genomic Health, Inc. | 21-Oct-14 | United States |
8,868,352 | Predicting response to chemotherapy using gene expression markers | Genomic Health, Inc. | 28-Oct-14 | United States |
8,855,941 | Method for examining prognosis of breast cancer | Osaka University | 7-Oct-14 | Japan |
DRUG | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,858,928 | Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy | bluebird bio, Inc. | 14-Oct-14 | United States |
8,865,667 | Higher-order cellular information processing devices | California Institute of Technology | 21-Oct-14 | United States |
8,865,667 | Higher-order cellular information processing devices | California Institute of Technology | 28-Oct-14 | United States |
8,859,626 | Anti-virulence compositions and methods | Case Western Reserve University | 14-Oct-14 | United States |
8,859,517 | Method of gene transfer for the treatment of recessive catecholaminergic polymorphic ventricular tachycardia (CPVT) | Fondazione Salvatore Maugeri Clinica del Lavoro e Della Riabilitazione | 14-Oct-14 | Italy |
8,865,185 | Methods of use for HSV-1 and HSV-2 vaccines | he Trustees of the University of Pennsylvania | 28-Oct-14 | United States |
8,871,194 | Method for transforming a hair follicle | Kao Corporation | 28-Oct-14 | Japan |
8,859,597 | Compounds that enhance Atoh1 expression | Massachusetts Eye & Ear Infirmary | 14-Oct-14 | United States |
8,858,942 | Antibodies directed to ERBB2 | MedImmune Limited | 14-Oct-14 | United Kingdom |
8,865,669 | DNA fragment and use thereof | National University Corporation Okayama University | 21-Oct-14 | Japan |
8,865,669 | DNA fragment and use thereof | National University Corporation Okayama University | 28-Oct-14 | Japan |
8,871,730 | Chemical modification of short small hairpin RNAs for inhibition of gene expression | SomaGenics Inc. | 28-Oct-14 | United States |
8,859,021 | Skin appearance through gene manipulation | Sytheon | 14-Oct-14 | United States |
8,871,751 | Compositions and methods relating to nuclear hormone and steroid hormone receptors including inhibitors of estrogen receptor alpha-mediated gene expression and inhibition of breast cancer | The Board of Trustees of the University of Illinois | 28-Oct-14 | United States |
8,865,185 | Methods of use for HSV-1 and HSV-2 vaccines | The Trustees of the University of Pennsylvania | 21-Oct-14 | United States |
8,871,711 | Fibroblast growth factor-9 promotes hair follicle regeneration after wounding | The Trustees of the University of Pennsylvania | 28-Oct-14 | United States |
8,871,223 | HSV-1 and HSV-2 vaccines and methods of use thereof | The Trustees of the University of Pennsylvania | 28-Oct-14 | United States |
8,859,562 | Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer | The University of Sheffield | 14-Oct-14 | United Kingdom |
8,852,598 | Puumala virus full-length M segment-based DNA vaccines | United States of America as represented by the Secretary of the Army | 7-Oct-14 | United States |
FOOD OR EDIBLE MATERIAL | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,865,241 | Mutant bacterial strains of the genus Sphingomonas deficient in production of polyhydroxybutyrate and a process of clarification of sphingans and compositions thereof | CP Kelco U.S., Inc. | 21-Oct-14 | United States |
8,865,241 | Mutant bacterial strains of the genus Sphingomonas deficient in production of polyhydroxybutyrate and a process of clarification of sphingans and compositions thereof | CP Kelco U.S., Inc. | 28-Oct-14 | United States |
MULTICELLULAR LIVING ORGANISMS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,853,496 | Plants tolerant to HPPD inhibitor herbicides | Bayer CropScience AG | 7-Oct-14 | Germany |
8,859,856 | Plants tolerant to HPPD inhibitor herbicides | Bayer CropScience AG | 14-Oct-14 | Germany |
8,853,495 | Plants tolerant to HPPD inhibitor herbicides | Bayer CropScience AG | 7-Oct-14 | Germany |
8,865,968 | Method for down-regulating gene expression in fungi | Devgen NV | 21-Oct-14 | Belgium |
8,865,968 | Method for down-regulating gene expression in fungi | Devgen NV | 28-Oct-14 | Belgium |
8,865,972 | Sulfonylurea-tolerant sunflower plants | E. I. du Pont de Nemours and Company | 21-Oct-14 | United States |
8,865,972 | Sulfonylurea-tolerant sunflower plants | E. I. du Pont de Nemours and Company | 28-Oct-14 | United States |
8,859,850 | Polynucleotide comprising sequences of wheat gliadins and use thereof for silencing by RNAi | Losado; Francisco Barro | 14-Oct-14 | Spain |
8,871,997 | Enhanced transgene expression by co-expression with a suppressor of post-transcriptional gene silencing (PTGS) | Plant Bioscience Limited | 28-Oct-14 | United Kingdom |
8,871,996 | Mice expressing human voltage-gated sodium channels | Regeneron Pharmaceuticals, Inc. | 28-Oct-14 | United States |
8,871,998 | Method for producing chrysanthemum plant having petals containing modified anthocyanin | Suntory Holdings Limited | 28-Oct-14 | Japan |
8,853,493 | Virus induced gene silencing (VIGS) for functional analysis of genes in cotton | Temasek Life Sciences Laboratory Limited | 7-Oct-14 | Singapore |
8,865,969 | Mutant plant, a method for producing thereof and a method of increasing frequency of a genetic recombination | Toyota Jidosha Kabushiki Kaisha | 21-Oct-14 | United States |
8,865,969 | Mutant plant, a method for producing thereof and a method of increasing frequency of a genetic recombination | Toyota Jidosha Kabushiki Kaisha | 28-Oct-14 | Japan |
8,853,364 | Prostate stem cell antigen (PSCA) variants and subsequences thereof | Agensys, Inc. | 7-Oct-14 | United States |
8,871,907 | Glycosylated immunoglobulin and immunoadhesin comprising the same | Korea Prime Pharm Co., Ltd | 28-Oct-14 | Korea |
8,853,370 | Plant-produced glycoprotein comprising human-type sugar chain | Phyton Holdings, LLC | 7-Oct-14 | United States |
8,859,727 | Bioactive FUS1 peptides and nanoparticle-polypeptide complexes | The Board of Regents of the University of Texas System | 14-Oct-14 | United States |
ORGANIC COMPOUNDS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,865,668 | Methods and compositions for increasing RNA interference | Devgen N.V. | 21-Oct-14 | Belgium |
8,865,668 | Methods and compositions for increasing RNA interference | Devgen N.V. | 28-Oct-14 | Belgium |
8,853,177 | Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto | Idera Pharmaceuticals, Inc. | 7-Oct-14 | United States |
8,853,380 | Modified SAK gene for the production of recombinant proteins | Lupin Limited | 7-Oct-14 | India |
8,853,384 | RNA interference mediating small RNA molecules | Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V. | 7-Oct-14 | Germany |
8,859,746 | Genome wide identification and characterization of gene expression regulatory elements in Zea mays for use in plants | Monsanto Technology LLC | 14-Oct-14 | United States |
8,871,918 | Multiple exon skipping compositions for DMD | Sarepta Therapeutics, Inc. | 28-Oct-14 | United States |
8,865,883 | Multiple exon skipping compositions for DMD | Sarepta Therapeutics, Inc. | 21-Oct-14 | United States |
8,865,883 | Multiple exon skipping compositions for DMD | Sarepta Therapeutics, Inc. | 28-Oct-14 | United States |
8,865,885 | MicroRNA fingerprints during human megakaryocytopoiesis | The Ohio State University Research Foundation | 21-Oct-14 | United States |
8,865,885 | MicroRNA fingerprints during human megakaryocytopoiesis | The Ohio State University Research Foundation | 28-Oct-14 | United States |
8,865,880 | Identification of a novel BHD gene | The United States of America as represented by the Secretary of the Department of Health and Human | 21-Oct-14 | United States |
8,865,880 | Identification of a novel BHD gene | The United States of America as represented by the Secretary of the Department of Health and Human Services | 28-Oct-14 | United States |
PLANTS | ||||
Pat No | Title | Assignee | Date Issued | Country |
PP25,018 | Gamagrass cultivar named `Eagle Point Devil Corn` | Eubanks; Mary Wilkes | 28-Oct-14 | United States |
Login
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.